Sun Pharma

Remdesivir shortage in Nagpur; Nitin Gadkari dials Sun Pharma chief

Remdesivir shortage in Nagpur; Nitin Gadkari dials Sun Pharma chief

Union minister Nitin Gadkari has called up Sun Pharma's chief to arrange for 10,000 injections of Remdesivir in Nagpur in view of a short...Read More

Sensex jumps over 300 pts: PowerGrid, M&M, NTPC, IndusInd Bank, Bajaj Finance, Sun Pharma, Dr Reddy's among gainers

Sensex jumps over 300 pts: PowerGrid, M&M, NTPC, IndusInd Bank, Bajaj Finance, Sun Pharma, Dr Reddy's among gainers

After starting on a weak note, equity benchmark Sensex rebounded over 300 points in early trade on Tuesday, tracking gains in index heavy...Read More

Eicher Motors, JSW Steel, Tata Motors, Hindalco, Tata Steel, Sun Pharma, Axis Bank and Tech Mahindra among others drove markets on Wednesday

Eicher Motors, JSW Steel, Tata Motors, Hindalco, Tata Steel, Sun Pharma, Axis Bank and Tech Mahindra among others drove markets on Wednesday

Equity benchmark indices closed half a per cent higher on Wednesday with IT, pharma and metal stocks trading firm throughout the session....Read More

Markets volatile: ITC, Maruti Suzuki, Asian Paints, Kotak Mahindra Bank, Sun Pharma among other drag the market

Markets volatile: ITC, Maruti Suzuki, Asian Paints, Kotak Mahindra Bank, Sun Pharma among other drag the market

Equity benchmark indices are trading in red after making gains earlier in the day. Sensex dropped by 79.50 points or 0.15 per cent to 51,...Read More

Sun Pharma, Dilip Shanghvi and other officials settle case of alleged market norms violation with Sebi

Sun Pharma, Dilip Shanghvi and other officials settle case of alleged market norms violation with Sebi

Sun Pharmaceutical Industries Ltd and its senior officials, including Managing Director Dilip Shanghvi, on Thursday settled with regulato...Read More

Top stocks: IndusInd Bank, Sun Pharma, PowerGrid, Cipla, Dr Reddy are up more than 4%

Top stocks: IndusInd Bank, Sun Pharma, PowerGrid, Cipla, Dr Reddy are up more than 4%

For the third consecutive day, the stock market is trading in green. At 12.30 pm, Sensex touched a new high at 50,377.15 points and Nift...Read More

Market in green: IndusInd Bank, Dr Reddy's, PowerGrid, Tech Mahindra, Sun Pharma, Axis Bank among top gainers

Market in green: IndusInd Bank, Dr Reddy's, PowerGrid, Tech Mahindra, Sun Pharma, Axis Bank among top gainers

Equity benchmark Sensex pared early losses and turned positive in opening trade on Wednesday amid gains in index-heavyweights Reliance, T...Read More

Sun Pharma Q2 net profit up 70% to Rs 1,813 crore

Sun Pharma Q2 net profit up 70% to Rs 1,813 crore

Drug major Sun Pharmaceutical Industries on Tuesday reported a 70.36 per cent jump in its consolidated net profit to Rs 1,812.79 crore fo...Read More

Market moves up: Sun Pharma, Tech Mahindra, Tata Steel, TCS, Titan, PowerGrid, Reliance Industries among gainers

Market moves up: Sun Pharma, Tech Mahindra, Tata Steel, TCS, Titan, PowerGrid, Reliance Industries among gainers

Domestic equity benchmark Sensex jumped nearly 200 points in early trade on Friday tracking gains in index majors TCS, Reliance Industrie...Read More

COVID-19 in India: Phase 2 clinical trial of Sun Pharma’s AQCH commences

COVID-19 in India: Phase 2 clinical trial of Sun Pharma’s AQCH commences

Pharmaceutical company, Sun Pharma, has commenced Phase 2 clinical trial on AQCH, a phytopharmaceutical (plant derived) drug for treatmen...Read More

COVID-19 in India: DCGI allows clinical trials of Sun Pharma’s Nafamostat

COVID-19 in India: DCGI allows clinical trials of Sun Pharma’s Nafamostat

Sun Pharmaceutical Industries received approval from the Drugs Controller General of India (DCGI) to initiate clinical trial with Nafamos...Read More

Sun Pharma Q3 net profit declines 27% to Rs 914 crore

Sun Pharma Q3 net profit declines 27% to Rs 914 crore

The company had posted a net profit of Rs 1,241.85 crore for the corresponding period of the previous fiscal, Sun Pharma said in a BSE fi...Read More

Mukesh Ambani stays richest Indian, Sun Pharma's Sanghavi slips to 10th

Mukesh Ambani stays richest Indian, Sun Pharma's Sanghavi slips to 10th

Mumbai: Dilip Sanghavi, the chairman of Sun Pharmaceuticals Ltd, slipped five spots to the 10th place in the IIFL Wealth-Hurun India Rich...Read More

Sun Pharma inks deal with China Medical Systems to commercialise 7 generic products

Sun Pharma inks deal with China Medical Systems to commercialise 7 generic products

The total addressable market size for all these eight products is about one billion dollars in Mainland China

Sun Pharma takes steps to ease governance woes

Sun Pharma takes steps to ease governance woes

New Delhi: In a bid to ease investor concerns over its corporate governance, Sun Pharma on Tuesday replaced its domestic formulations dis...Read More

Something ‘Shady’ at Sun Pharmaceuticals shatters the rosy picture?

Something ‘Shady’ at Sun Pharmaceuticals shatters the rosy picture?

Mumbai: After the markets opened for trade today, shares of Sun Pharmaceutical Industries Ltd. sunk by more than 12% to around Rs. 370 a ...Read More

Sun Pharma under cloud amid insider trading allegations

Sun Pharma under cloud amid insider trading allegations

Mumbai: Markets regulator Sebi is likely to reopen an insider trading case against Sun Pharmaceutical Industries as well as probe alleged...Read More

Sensex falls 188 points on global cues, weak macro data

Sensex falls 188 points on global cues, weak macro data

Mumbai: Benchmark Sensex tumbled over 188 points to close at 37,663.56 today, tracking weak global cues on concerns over Turkey’s financi...Read More

Sensex rebounds 200 pts as July F&O series opens strong

Sensex rebounds 200 pts as July F&O series opens strong

Mumbai: Reversing a two-session slide, the benchmark BSE Sensex rose over 200 points and the Nifty reclaimed the 10,600-mark in early tra...Read More

Sensex gains 147 pts on firm global cues, Nifty reclaims 10,600

Sensex gains 147 pts on firm global cues, Nifty reclaims 10,600

Mumbai: The benchmark BSE Sensex rose 147 points and Nifty reclaimed 10,600 mark in early trade today on sustained buying by domestic ins...Read More

Free Press Journal

www.freepressjournal.in